Clinic for Heart Surgery, University Clinic of the Martin Luther University, Halle, Germany.
Institute of Biochemistry, Carleton University4, Ottawa, ON, Canada.
Adv Exp Med Biol. 2020;1260:319-332. doi: 10.1007/978-3-030-42667-5_13.
Metformin is a safe, effective and useful drug for glucose management in patients with diabetes. However in recent years, more attention has been paid to the possibility of using metformin as an anti-aging drug. It was shown to significantly increase the lifespan in some model organisms and delay the onset of age-associated declines. The current review summarizes advances in clinical research on the potential role of metformin in the field of lifespan and healthspan extension. Growing amounts of evidence from clinical trials suggest that metformin can effectively reduce the risk of many age-related diseases and conditions, including cardiometabolic disorders, neurodegeneration, chronic inflammation and frailty. Metformin also holds promise as a drug that could be repurposed for chemoprevention or adjuvant therapy for certain types of cancer. Moreover, metformin induces autophagy by activation of AMPK and can thus be potentially used to promote heathspan by hormesis-like mechanisms. Although long-term intake of metformin is associated with low risk of adverse events, well-designed clinical trials are still required to uncover the potential use of this drug as a geroprotector.
二甲双胍是一种安全、有效且有用的糖尿病患者血糖管理药物。然而,近年来,人们越来越关注将二甲双胍用作抗衰老药物的可能性。研究表明,它能显著延长某些模式生物的寿命并延缓与年龄相关的衰退的发生。目前的综述总结了关于二甲双胍在延长寿命和健康寿命方面的潜在作用的临床研究进展。越来越多的临床试验证据表明,二甲双胍能有效降低多种与年龄相关的疾病和病症的风险,包括心血管代谢紊乱、神经退行性变、慢性炎症和虚弱。二甲双胍也有望成为一种可用于预防某些类型癌症的化学预防或辅助治疗的药物。此外,二甲双胍通过激活 AMPK 诱导自噬,因此可以通过类似应激的机制潜在地用于促进健康寿命。尽管长期服用二甲双胍与不良反应风险低相关,但仍需要精心设计的临床试验来揭示这种药物作为抗衰老保护剂的潜在用途。